Objects: To compare first trimesterscrening (FTS) serum markers free β-human chorionic gonodotropin (free β-hCG and pregnancy associated plasma protein A (PAPP-A) of blastocyst versus cleavage stage embryo transfers after assisted reproductive technologies (ART).
INTRODUCTION
The blastocyst transferences established on an advanced culture structure have been proven efficient to select embryos, which results in an increased implantation ratio besides not effecting pregnancy ratio (1) .İncreased implantation ratios can let less-transferring but morequalified embryos at the blastocyst phase, in this way it can be ensured to avoid from multiple pregnancy incidences (2) . Time extension of embryo culture to the blastocyst phase for ART presents a number of theoretic benefits for the transference of cleavage-phase embryos.Some of the benefits are: 1) decreasingembryos' being exposed to hyper-induced uterine circumference to minimum level, 2) providing a rather good physiologic synchronicity between embryo layer and the endometrium during embryos transference (3) , 3) making the most effective and optimized election of embryos which have the higher implantation capacity, 4) boosting the probability to went through cryopreservation, and 5) decreasing uterine spasms, etc.Nevertheless, there is some particular disadvantages in blastocyst phase.
By use of todays methods, several cleavage embryos can't evolve into blastocysts in vitro and cryopreservation of several blastocysts can't be ensured in good way. Hence, there is questions yet over if the transference of blastocyst-phase embryos is useful to entire patients who is not fertile (4) (5) (6) (7) (8) .
FTS unites the mother age connected risks with the measurements of biochemical markers (free β-hCG and PAPP-A) and fetal nuchal translucency (NT) to estimate Down Syndrome (DS) (trisomy21), Edwards Syndrome (ES) (trisomy18) and Patau Syndrome (PS) (trisomy13) risks. This test uses the motherhood blood amounts of free β-hCG and PAPP-A and the measurements of the NT and crown rump length (CRL) by US method in the period of 11+3rd and 13+6th weeks pregnancy (9) .The motherhood serum amounts of PAPP-A and free The combine FTS has 95 percent perception ratio for DS (9) , with 5 percent monitor-positive ratio (10) . An increased threat, or monitor-positive combine FTS outcome shows that the defined danger based on the US and biochemistry is higher than 1 in 300. Plenty of monitorpositives are not affected from aneuploidy,for this reason they may be incorrect-positives (9) .
The perception ratio can be made higher up to 95 percent, decreasing the incorrectpositive ratio to lesser than 3 percent with the inclusion of extra US markers (nasal bone, ductus venosus or tricuspid Doppler) (11, 12) . The scanning test elements must be set by use of several factors which can change US or biochemical markers for improving it's correctness. Some of the factors are: pregnancy and motherhood features such as pregnancy age, mother weight, ethnicity, smoke dependence, diabetes mellitus and pregnancy way (11) (12) (13) (14) (15) .
Today, 1 to 4 percent of infants born in entire advanced countries became pregnant thanks to ART (16, 17) . Differentiations in serum levels and fetal NT were evaluated with the Kruskal-Wallis testing.
Material and Methods

This retrospective research was confirmed within the Ethics
Meaning was accepted at p<0.05.
Results
First chart summarizes motherhood features and pregnancy age at case exemplifications. No differences appeared between 3rd and 5th day embryo transference according to motherhood age (p=0.616) and weight (p=0.693).It wasn't seen any differentiation of pregnancy age in exemplification in both groups. (p=0.742). Chart 2 shows ultrasound markers and biochemistry markers of the cases.However, day-3 transfer patients presented meaningfully low PAPP-A MoM datas than day 5 transfer patients (p=0.031).There weren't significant differentiation of free β-hCG amounts in both groups (p=0.371). NT was unaffected by the transferenceday (p=0.21). Also CRL wasunaffected by the transference day (p=0.693). 
Discussion
Serum proteins are synthetized by placenta (PAPP-A, free β-hCG, hCG and unconjugated estriol (uE3) and by the fetus (alpha fetoprotein (AFP)). Motherhood serum amount of AFP in second trimester (ST) is produced by malformed alteration of the fetal liver in DS embryos (18) , the alterations in the amounts of placenta-provided proteins weren't took into account.Recent researches have shown that the synthetis of placenta-produced proteins in DS and normal placentae has differences from cyto-to syncytiotrophoblast that is distrupted in DS placenta, pursued by a changing of the synthetis of placenta-produced proteins (19) .The free β-hCG has been described as the preferable calculation value in scanning DS, in spite of the fact that it has not been verified in any researches which have been carried out till today (20, 21 ) .Free β-hCG is necessary for the maintaining of pregnancy. This serum marker first gets higher till 10th week of pregnancy and after gets lower toward term (22, 23) .In FT of pregnancy, increased amounts of free β-hCG are related to DS, and in the ST related to bad obstetric result (24, 25, 26) .The differentiation between the two amounts of β-hCG is related to the effects of unfavorable pregnancies and advancing GA (26) .
The amount of free β-hCG is low when FT IVF is compared with usual pregnancy (27) , whereas in the ST free β-hCG is high in IVF pregnancy (28) (29) (30) .
The low amount of PAPP-A observed in DS pregnancy indicates a common crisis of the insulin-like development component axis in DS pregnancy (31, 32) .Because IGFs are included in trophoblast incursion, alterations in the bioavailability of these hormones may be associated with the higher ratio of pregnancy problems depended on DS pregnancy.Low motherhood serum amounts of PAPP-A in DS pregnancy is not particular, because diminished amounts of PAPP-A are observed in pregnancies of pre-eclampsia and intrauterine growing delay (18, 19) . Informed Consent: Informed consent was not received on account of the retrospective content of the study.
